Skip to main content
. 2018 Nov 8;10:80. doi: 10.1186/s13098-018-0384-8

Table 2.

End of trial means of metabolic characteristic across the study groups

Variables Groups (n = 141) P valueg
Vit D (n = 24)a Vita D + PA (n = 21)b Vit C (n = 26)c Vit C + PA (n = 23)d Placebo (n = 25)e Placebo + PA (n = 22)f
Weight (kg) 84.9 ± 16.7 79 ± 11 79.5 ± 12.9 77.9 ± 13.4 82.3 ± 13.8 73.6 ± 12.5 .124
BMI (kg/m2) 33.3 ± 6 32.2 ± 4 311.4 ± 6 31.7 ± 5.6 32.8 ± 4.2 29.7 ± 4.7 .231
WC (cm) 109.1 ± 8.2 107.2 ± 7.5 107 ± 9.9 103.6 ± 8.4 106.2 ± 9.7 107.9 ± 10.4 .442
FPG (mg/dL) 97.8 ± 7.7 97.7 ± 8.7 105 ± 13.3 100.7 ± 8.4 108 ± 19.2 98.9 ± 10.7 .012
SBP (mmHg) 121.3 ± 9.2 126.2 ± 8.9 129.2 ± 8.6 173 ± 252.4 126.6 ± 12 123 ± 12 .514
DBP (mmHg) 80.1 ± 5.8 81.7 ± 5.3 81.9 ± 5 79.6 ± 4.5 81.6 ± 6.7 80.2 ± 6.7 .643
TC (mg/dL) 160.5 ± 33.4 81.7 ± 31.3 180.2 ± 31.9 175.1 ± 29.9 196.8 ± 39.4 184.8 ± 28.1 .009
TG (mg/dL) 233.8 ± 97 178 ± 80.8 246.1 ± 90.3 151.2 ± 53.8 158.6 ± 35.4 155.6 ± 57.7 .001
LDL-C (mg/dL) 107 ± 36.6 138.3 ± 31.4 124.3 ± 39.6 134.5 ± 28.2 158.8 ± 39 145.8 ± 30.2 .001
HDL-C (mg/dL) 33.7 ± 10.6 39.1 ± 10 33.2 ± 10.1 51.9 ± 20.6 31.8 ± 7.1 38.9 ± 9.8 .001
Vit D (ng/mL) 23.2 ± 4.9 29 ± 5.5 12.6 ± 4 18.9 ± 4.5 .001
Vit C (ng/mL) 1.4 ± .3 1.7 ± .3 .9 ± .4 1.1 ± .3 .001

Data are mean ± standard deviation (SD)

PA, physical activity; BMI, body mass index; WC, waist circumferences; FPG, fasting blood sugar; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol

aReceiving 2000 IU vitamin D per day

bReceiving 2000 IU vitamin D per day plus 30 min endurance physical activity

cReceiving 500 mg vitamin C per day

dReceiving 500 mg vitamin C per day plus 30 min endurance physical activity

eReceiving one placebo per day

fReceiving one placebo per day plus 30 min endurance physical activity

gObtained from ANOVA or Chi square test, where appropriate